Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2005-1-20
pubmed:abstractText
DNA damage activates the monoubiquitination of the Fanconi anemia (FA) protein, FANCD2, resulting in the assembly of FANCD2 nuclear foci. In the current study, we characterize structural features of FANCD2 required for this intranuclear translocation. We have previously identified 2 normal mRNA splice variants of FANCD2, one containing exon 44 sequence at the 3' end (FANCD2-44) and one containing exon 43 sequence (FANCD2-43). The 2 predicted FANCD2 proteins differ in their carboxy terminal 24 amino acids. In stably transfected FANCD2(-/-) fibroblasts, FANCD2-44 and FANCD2-43 proteins were monoubiquitinated on K561. Only FANCD2-44 corrected the mitomycin C (MMC) sensitivity of the transfected cells. We find that monoubiquitinated FANCD2-44 was translocated from the soluble nuclear compartment into chromatin. A mutant form of FANCD2-44 (FANCD2-K561R) was not monoubiquitinated and failed to bind chromatin. A truncated FANCD2 protein (Exon44-T), lacking the carboxy terminal 24 amino acids encoded by exon 44 but retaining K561, and another mutant FANCD2 protein, with a single amino acid substitution at a conserved residue within the C-terminal 24 amino acids (D1428A), were monoubiquitinated. Both mutants were targeted to chromatin but failed to correct MMC sensitivity. Taken together, our results indicate that monoubiquitination of FANCD2 regulates chromatin binding and that D1428 within the carboxy terminal acidic sequence encoded by exon 44 is independently required for functional complementation of FA-D2 cells. We hypothesize that the carboxy terminus of FANCD2-44 plays a critical role in sensing or repairing DNA damage.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1003-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:15454491-Cell Cycle, pubmed-meshheading:15454491-Cells, Cultured, pubmed-meshheading:15454491-Chromatin, pubmed-meshheading:15454491-DNA Damage, pubmed-meshheading:15454491-DNA Repair, pubmed-meshheading:15454491-Fanconi Anemia, pubmed-meshheading:15454491-Fanconi Anemia Complementation Group D2 Protein, pubmed-meshheading:15454491-Genetic Variation, pubmed-meshheading:15454491-HeLa Cells, pubmed-meshheading:15454491-Humans, pubmed-meshheading:15454491-Microscopy, Fluorescence, pubmed-meshheading:15454491-Mitomycin, pubmed-meshheading:15454491-Nuclear Proteins, pubmed-meshheading:15454491-Protein Binding, pubmed-meshheading:15454491-RNA, Messenger, pubmed-meshheading:15454491-RNA Splicing, pubmed-meshheading:15454491-Sequence Deletion, pubmed-meshheading:15454491-Ubiquitin
pubmed:year
2005
pubmed:articleTitle
Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin.
pubmed:affiliation
Dana-Farber Cancer Institute, Department of Radiation Oncology, Harvard Medical School, 44 Binney St, Boston, MA 02115, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't